Patterning Effects of FGF17 and cAMP on Generation of Dopaminergic Progenitors for Cell Replacement Therapy in Parkinson’S Disease

Scientists explored the application of alternative midbrain-hindbrain boundary-secreted fibroblast growth factor (FGF)-family members, FGF17, and FGF18, for ventral midbrain dopaminergic progenitor patterning.